FSNUY — Fresenius SE & Co. KGaA

—
OTC · Health Care · Health Care Equipment & Supplies · CIK 904868 ·
Last close
$14.78
Market Cap
$33.30B
52W High
$15.51
52W Low
$10.33
ADV30
174,060
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 5,884,000,000 1,533,000,000 574,000,000 371,000,000 42,245,000,000 1,715,000,000 21,489,000,000
Jun 2026 5,945,000,000 1,550,000,000 632,000,000 382,000,000 41,844,000,000 1,279,000,000 21,445,000,000
Mar 2026 5,818,000,000 1,534,000,000 601,000,000 435,000,000 42,370,000,000 2,059,000,000 21,905,000,000
Dec 2025 6,156,000,000 1,524,000,000 468,400,000 361,000,000 41,395,000,000 1,307,000,000 21,628,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,710,000,000
Investing CF
$-197,000,000
Financing CF
$-3,203,000,000
CapEx
$-1,476,000,000
Dividends Paid
$-684,000,000
Buybacks
—
EPS Diluted TTM
$0.67
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
—
Inventory
$2,782,000,000
Receivables
—
ST Investments
$134,000,000
EBIT TTM
$2,727,000,000
Pretax Income TTM
$2,245,000,000
Interest Exp TTM
—
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$23,281,000,448
EBITDA
$3,039,000,064
Free Cash Flow
$1,710,125,056
Enterprise Value
$40,331,104,256
Total Cash
$1,279,000,064
Total Debt
$11,418,999,808
Shares Out
2,252,949,108
Trailing EPS
$0.81
Book Value
$10.14
ROE
8.3%
ROA
3.4%
Div Yield
2.33%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 22,873,000,000 2,181,400,000 1,264,000,000 41,395,000,000 21,628,000,000 19,104,000,000 2,574,000,000
Dec 2024 21,954,000,000 2,073,000,000 471,000,000 43,550,000,000 23,260,000,000 19,542,000,000 2,447,000,000
Dec 2023 21,067,000,000 1,183,000,000 -594,000,000 45,284,000,000 25,633,000,000 18,999,000,000 4,456,000,000
Dec 2022 21,532,000,000 1,812,000,000 1,372,000,000 76,400,000,000 44,182,000,000 20,415,000,000 4,198,000,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$2.89

Peers — same industry

TickerNameMarket CapLastDaily %
RMD RESMED INC $33.46B $237.85 —
MDLN Medline Inc. $33.11B $37.68 —
DXCM DEXCOM INC $30.60B $82.04 —
GEHC GE HealthCare Technologies Inc. $37.00B $81.84 —
PHG KONINKLIJKE PHILIPS NV $29.22B $29.89 —

News headlines (Yahoo Finance, 1h cache)

mAbxience and OncoPrecision Announce Manufacturing and Investment Agreement for OncoPrecision's ADC Candidate ONC001
2026-11-18 13:00 · Yahoo
Fresenius Kabi Launches Denosumab Biosimilars in Canada, with the First and Only Ready-to-Use Pre-Filled Syringe Biosimilar for Oncology
2026-11-16 13:00 · Yahoo
Is Fresenius SE KGaA (XTRA:FRE) Fairly Valued As Earnings And Its WuXi Deal Lift Interest?
2026-11-11 01:11 · Yahoo
What Akebia Therapeutics (AKBA) Said on Its Q3 Earnings Call
2026-11-05 16:15 · Yahoo
Fresenius SE & Co KGaA (FSNUF) Q3 2026 Earnings Call Highlights: Raised Guidance, Record ...
2026-11-04 23:08 · Yahoo
Fresenius raises 2026 earnings outlook after Q3 profit beats estimates
2026-11-04 06:32 · Yahoo
Fresenius: Q3 Earnings Snapshot
2026-11-03 08:01 · Yahoo
Fresenius and WuXi Bio team up in 37-strong biosimilar development deal
2026-11-02 17:35 · Yahoo
Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline
2026-11-02 06:47 · Yahoo
Is Fresenius SE KGaA (XTRA:FRE) Still A Bargain On Earnings?
2026-11-01 16:10 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.